Ruthenium-red-induced cell agglutination and surface glycoprotein and mucopolysaccharide.
D000371:Agglutination / Q000187:drug effects*; D000372:Agglutination Tests; D000818:Animals; D001665:Binding Sites; D006528:Carcinoma, Hepatocellular; D002594:Cetylpyridinium / Q000494:pharmacology; D002807:Chondroitin / Q000494:pharmacology; D002845:Chromatography; D004396:Coloring Agents / Q000494:pharmacology*; D004591:Electrophoresis, Polyacrylamide Gel; D005947:Glucose / Q000494:pharmacology; D006023:Glycoproteins / Q000032:analysis*; D006025:Glycosaminoglycans / Q000032:analysis*; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology; D007811:Lanthanum / Q000494:pharmacology; D008113:Liver Neoplasms; D051379:Mice; D008854:Microscopy, Electron; D009374:Neoplasms, Experimental; D010206:Papain / Q000494:pharmacology; D051381:Rats; D012428:Ruthenium / Q000494:pharmacology*; D013194:Staining and Labeling; D014357:Trypsin / Q000494:pharmacology
D004396:Coloring Agents; D006023:Glycoproteins; D006025:Glycosaminoglycans; D007811:Lanthanum; D012428:Ruthenium; D002807:Chondroitin; D002594:Cetylpyridinium; D006821:Hyaluronoglucosaminidase; D014357:Trypsin; D010206:Papain; D005947:Glucose